Menu
Recruiting NCT03260842

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Observational Pancreatic Cyst Pancreas Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Bio-Specimen Collection.
Who it may be relevant to
Registry conditions: Pancreatic Cyst, Pancreas Disease. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Bio-repository to collect bio-specimens from patients with 1) pancreatic cysts and 2) patients at high risk, defined by family history and/or genetic mutations, for pancreatic cancer.

Detailed description

Observational study to collect bio-specimens from 2 separate patient cohorts identified to be at high risk for subsequent development of pancreas cancer.

1. Patients diagnosed with a pancreatic cyst undergoing either endoscopic ultrasound or surgery. Bio-specimens collected include pancreatic cyst fluid and blood. These will be collected using a standard operating protocol. 2. Patients defined as a high risk individual for pancreas cancer by family history and/or known genetic mutations. Bio-specimens collected include blood. This will be collected using a standard operating protocol.

Interventions

  • Diagnostic test Bio-Specimen Collection
    Collection of bio-specimens and observation over time.

Primary outcome measures

  • Pancreas Cancer [Time frame: 5-10 years]

Eligibility criteria

Inclusion criteria

  • Older than 18 with pancreas cyst
  • Older than 18 at high risk for Pancreas cancer

Exclusion criteria

  • Unable to provide consent
  • Not willing to provide bio-specimens

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Stanford University — Stanford

Identifiers

NCT: NCT03260842 · IRB-19286

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗